Associated Papers
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.
Wolff JH et al.
Nature Communications, 2025
Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.
Erman B et al.
Journal of Clinical Immunology, 2024
Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature.
Marzollo A et al.
Journal of Clinical Immunology, 2022
Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.
Chan KW et al.
Frontiers in Immunology, 2022
Bacillus Calmette-Guérin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
Ishikawa T et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2021
Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.
Akar HT et al.
Journal of Clinical Immunology, 2021
The Evaluation of DHR Histogram Pattern in Chronic Granulomatous Disease and MPO Deficiency.
Köker MY et al.
Chest, 2021
Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease.
Chiu TL et al.
Frontiers in Immunology, 2021
Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.
Aygun D et al.
International Archives of Allergy and Immunology, 2020
Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.
Wang S et al.
Journal of Clinical Immunology, 2019
Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly.
O'Neill S et al.
The Journal of Biological Chemistry, 2018
A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017).
Zhou Q et al.
Journal of Clinical Immunology, 2018
Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
Badalzadeh M et al.
International Journal of Immunogenetics, 2017
CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.
Stasia MJ
Gene, 2016
A new autosomal recessive, heterozygous pair of mutations of CYBA in a patient with chronic granulomatous disease.
Chang YH et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, 2010
Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).
Roos D et al.
Blood Cells, Molecules & Diseases, 2010
Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease.
Köker MY et al.
European Journal of Clinical Investigation, 2009
Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F et al.
Human Genetics, 2000
[Prospects for gene therapy for chronic granulomatous disease with gp91-phox deficiency].
Nunoi H et al.
[rinsho Ketsueki] the Japanese Journal of Clinical Hematology, 1998
Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
Mortaz E et al.
International Archives of Allergy and Immunology, 0